Breaking News
Get 40% Off 0
👀 Reveal Warren Buffett's stock picks that are beating the S&P 500 by +174.3% Get 40% Off
Close

Bristol-Myers Squibb Company (BMY)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Bristol-Myers Squibb's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
50.93 +0.42    +0.83%
08:00:00 - Closed. Currency in USD ( Disclaimer )
Pre Market
50.92
-0.01
-0.02%
23:20:29 - Real-time Data
  • Volume: 7,585,243
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 50.38 - 50.97
Type:  Equity
Market:  United States
Bristol-Myers Squibb 50.93 +0.42 +0.83%

BMY Income Statement

 
Featured here, the Income Statement (earnings report) for Bristol-Myers Squibb Company, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Revenue 11477 10966 11226 11337
Revenue 11477 10966 11226 11337
Other Revenue, Total - - - -
Cost of Revenue, Total 2707 2490 2809 2512
Gross Profit 8770 8476 8417 8825
Total Operating Expenses 9525 8862 9232 8831
Selling/General/Admin. Expenses, Total 2064 1938 1914 1762
Research & Development 2476 2178 2252 2301
Depreciation / Amortization - - - -
Interest Expense (Income) - Net Operating -311 -280 -273 -262
Unusual Expense (Income) - - - -
Other Operating Expenses, Total 2589 2536 2530 2518
Operating Income 1952 2104 1994 2506
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets 78 - -47 -135
Other, Net 200 -33 182 -129
Net Income Before Taxes 1674 2137 1859 2770
Provision for Income Taxes -88 203 -218 503
Net Income After Taxes 1762 1934 2077 2267
Minority Interest 55 64 57 62
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 1762 1928 2073 2262
Total Extraordinary Items - - - -
Net Income 1762 1928 2073 2262
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 1762 1928 2073 2262
Dilution Adjustment -1.01 8.48 -7.98 1.09
Diluted Net Income 1763.01 1919.52 2080.98 2260.91
Diluted Weighted Average Shares 2033 2064 2102 2113
Diluted EPS Excluding Extraordinary Items 0.867 0.93 0.99 1.07
DPS - Common Stock Primary Issue 0.6 0.57 0.57 0.57
Diluted Normalized EPS 0.714 0.761 0.689 0.844
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BMY Comments

Write your thoughts about Bristol-Myers Squibb Company
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email